학술논문

Ionis Pharmaceuticals-Exact Sciences ALS Genetic Testing Program results in 4% ATXN2-positive yield
Document Type
Journal
Source
MUSCLE & NERVE; 2023, 68 pS18-pS18, 1p. Supplement: 1
Subject
Language
English
ISSN
10974598